These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 26446417)
41. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells. Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077 [TBL] [Abstract][Full Text] [Related]
42. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition. Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949 [TBL] [Abstract][Full Text] [Related]
43. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway. Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303 [TBL] [Abstract][Full Text] [Related]
44. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis. Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305 [TBL] [Abstract][Full Text] [Related]
46. microRNA-21 mediates epithelial-mesenchymal transition of human hepatocytes via PTEN/Akt pathway. Liu Z; Wang J; Guo C; Fan X Biomed Pharmacother; 2015 Feb; 69():24-8. PubMed ID: 25661333 [TBL] [Abstract][Full Text] [Related]
47. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway. Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131 [TBL] [Abstract][Full Text] [Related]
48. Activation of phosphatidylinositol 3-kinase/Akt signaling mediates sorafenib-induced invasion and metastasis in hepatocellular carcinoma. Wang H; Xu L; Zhu X; Wang P; Chi H; Meng Z Oncol Rep; 2014 Oct; 32(4):1465-72. PubMed ID: 25070581 [TBL] [Abstract][Full Text] [Related]
49. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α. Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151 [TBL] [Abstract][Full Text] [Related]
50. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition. Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544 [TBL] [Abstract][Full Text] [Related]
51. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145. Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342 [TBL] [Abstract][Full Text] [Related]
52. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT. Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801 [TBL] [Abstract][Full Text] [Related]
53. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway. Zhang X; Shi H; Tang H; Fang Z; Wang J; Cui S Int J Mol Med; 2015 May; 35(5):1301-8. PubMed ID: 25760926 [TBL] [Abstract][Full Text] [Related]
54. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752 [TBL] [Abstract][Full Text] [Related]
55. Normal endometrial stromal cells regulate 17β-estradiol-induced epithelial-mesenchymal transition via slug and E-cadherin in endometrial adenocarcinoma cells in vitro. Zhang H; Li H; Qi S; Liu Z; Fu Y; Li M; Zhao X Gynecol Endocrinol; 2017 Jan; 33(1):82-86. PubMed ID: 27449470 [TBL] [Abstract][Full Text] [Related]
56. MiR-501 promotes tumor proliferation and metastasis by targeting HOXD10 in endometrial cancer. Sun X; Hou L; Qiu C; Kong B Cell Mol Biol Lett; 2021 May; 26(1):20. PubMed ID: 34022794 [TBL] [Abstract][Full Text] [Related]
57. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9. Lu MH; Huang CC; Pan MR; Chen HH; Hung WC Clin Cancer Res; 2012 Dec; 18(23):6416-25. PubMed ID: 23045246 [TBL] [Abstract][Full Text] [Related]
58. miR-21 and KLF4 jointly augment epithelial‑mesenchymal transition via the Akt/ERK1/2 pathway. Liu CH; Huang Q; Jin ZY; Zhu CL; Liu Z; Wang C Int J Oncol; 2017 Apr; 50(4):1109-1115. PubMed ID: 28197636 [TBL] [Abstract][Full Text] [Related]
59. miR-466 and NUS1 Regulate the AKT/Nuclear Factor kappa B (NFκB) Signaling Pathway in Intrauterine Adhesions in a Rat Model. Liu M; Zhao D; Wu X; Guo S; Yan L; Zhao S; Li H; Wang Y; Rong F Med Sci Monit; 2019 Jun; 25():4094-4103. PubMed ID: 31154456 [TBL] [Abstract][Full Text] [Related]
60. Periostin Facilitates the Epithelial-Mesenchymal Transition of Endometrial Epithelial Cells through ILK-Akt Signaling Pathway. Zheng QM; Lu JJ; Zhao J; Wei X; Wang L; Liu PS Biomed Res Int; 2016; 2016():9842619. PubMed ID: 27034956 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]